Status:
COMPLETED
Use of Incretins in Diabetic Patients
Lead Sponsor:
University of Pavia
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
Observational, retrospective study, conducted in diabetic patients aimed to evaluate the effects on the glyco-metabolic control and on cardiovascular events of different DPP-4 inhibitors. Patients wil...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients
- On oral hypoglycemic agents ± basal insulin
- In primary and secondary prevention
Exclusion
- \- Patients with a follow-up of less than 8 years
Key Trial Info
Start Date :
March 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2021
Estimated Enrollment :
2234 Patients enrolled
Trial Details
Trial ID
NCT03486964
Start Date
March 27 2018
End Date
May 30 2021
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico San Matteo Foundation
Pavia, Lombardy, Italy, 27100